Publications by authors named "Alexandre Vivot"

Claim this Profile
A
Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries.
Perrine Créquit, Alexandre Vivot, Jules Grégory, Bernard Milleron

J Cancer Policy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.
Xavier Puéchal, Michele Iudici, Ana Luisa Calich, Alexandre Vivot, Benjamin Terrier

Rheumatology (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian analysis from phase III trials was underused and poorly reported: a systematic review.
David Ferreira, Alexandre Vivot, Pierre Diemunsch, Nicolas Meyer

J Clin Epidemiol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Basic Epidemiologic Principles and Electronic Health Records in a Deep Learning Prediction Model.
Alexandre Vivot, Jules Grégory, Raphaël Porcher

JAMA Dermatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Methodologic Systematic Review of Mobile Health Behavior Change Randomized Trials.
Theodora Oikonomidi, Alexandre Vivot, Viet-Thi Tran, Carolina Riveros, Elisabeth Robin

Am J Prev Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Late-Life Expectancy for Assessing the Long-Term Benefit of Immune Checkpoint Inhibitors.
Alexandre Vivot, Perrine Créquit, Raphaël Porcher

J Natl Cancer Inst· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living network meta-analysis was feasible when considering the pace of evidence generation.
Perrine Créquit, Tania Martin-Montoya, Nassima Attiche, Ludovic Trinquart, Alexandre Vivot

J Clin Epidemiol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients.
Xavier Puéchal, Michele Iudici, Ana Luisa Calich, Alexandre Vivot, Benjamin Terrier

Rheumatology (Oxford)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Biomarker-based Design Strategies on the Risk of False-Positive Findings in Targeted Therapy Evaluation.
Tat-Thang Vo, Alexandre Vivot, Raphaël Porcher

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study.
Charlène Herbemont, Sarah Chekroune, Sarah Bonan, Isabelle Cedrin-Durnerin, Alexandre Vivot

Fertil Steril· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.
Jean-David Zeitoun, Joseph S Ross, Ignacio Atal, Alexandre Vivot, Nicholas S Downing

Clin Pharmacol Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving on Tail-of-the-Curve Evaluation With the American Society of Clinical Oncology Value Framework.
Alexandre Vivot, Perrine Créquit, Raphaël Porcher

JAMA Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of Crowdsourcing in Health: Systematic Review.
Perrine Créquit, Ghizlène Mansouri, Mehdi Benchoufi, Alexandre Vivot, Philippe Ravaud

J Med Internet Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.
Jean-David Zeitoun, Gabriel Baron, Alexandre Vivot, Ignacio Atal, Nicholas S Downing

Int J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.
Jean-David Zeitoun, Joseph S Ross, Ignacio Atal, Alexandre Vivot, Nicholas S Downing

BMJ Open· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up.
Jessica R Marden, Elizabeth R Mayeda, Stefan Walter, Alexandre Vivot, Eric J Tchetgen Tchetgen

Alzheimer Dis Assoc Disord· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality?
Charlene Herbemont, Solmaz Sarandi, Jeremy Boujenah, Isabelle Cedrin-Durnerin, Nathalie Sermondade, Alexandre Vivot

Reprod Biomed Online· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing.
Alexandre Vivot, Isabelle Boutron, Geoffroy Béraud-Chaulet, Jean-David Zeitoun, Philippe Ravaud

Sci Rep· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov.
Alexandre Vivot, Jacques Li, Jean-David Zeitoun, Samia Mourah, Perrine Crequit

Genet Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jump, Hop, or Skip: Modeling Practice Effects in Studies of Determinants of Cognitive Change in Older Adults.
Alexandre Vivot, Melinda C Power, M Maria Glymour, Elizabeth R Mayeda, Andreana Benitez

Am J Epidemiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
Alexandre Vivot, Isabelle Boutron, Philippe Ravaud, Raphaël Porcher

Genet Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
Marie Danet-Lamasou, Julien Asselineau, Paul Perez, Alexandre Vivot, Marie-Laure Nunes

Clin Endocrinol (Oxf)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.
Philippe Morlat, Alexandre Vivot, Marie-Anne Vandenhende, Frédéric-Antoine Dauchy, Julien Asselineau

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact.
Marie-Laure Jullié, Martina Carlotti, Alexandre Vivot, Marie Beylot-Barry, Nicolas Ortonne

Am J Surg Pathol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, open-label, non-comparative study of Botulinum toxin in Restless Legs Syndrome.
Imad Ghorayeb, Antoine Bénard, Alexandre Vivot, François Tison, Pierre Burbaud

Sleep Med· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis